Mind Medicine (MindMed) Inc., a clinical biopharmaceutical company, has announced new compensation terms for three newly hired non-executive employees. The company has issued inducement grants comprising options to purchase a total of 182,800 common shares. These options, with grant dates of September 15 and September 22, 2025, will vest over four years. Initially, 25% of the options will vest on the first anniversary of the grant date, with the remaining 75% vesting in equal monthly increments over the subsequent three years. The exercise price for the options is set at the closing price of MindMed's common shares on their respective grant dates.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mind Medicine (MindMed) Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250922211893) on September 22, 2025, and is solely responsible for the information contained therein.